JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-4.41%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$43.9M
AUM Growth
+$43.9M
(-14%)
Cap. Flow
-$302K
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
73.51%
Holding
47
New
7
Increased
2
Reduced
21
Closed
7
Top Buys
| 1 |
NGD
New Gold Inc
NGD
|
$3.5M |
| 2 |
Telecom Argentina
TEO
|
$853K |
| 3 |
Banco Macro
BMA
|
$834K |
| 4 |
Galicia Financial Group
GGAL
|
$820K |
| 5 |
YPF
YPF
|
$817K |
Top Sells
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$2.85M |
| 2 |
StoneCo
STNE
|
$2.55M |
| 3 |
Itaú Unibanco
ITUB
|
$1.32M |
| 4 |
UnitedHealth
UNH
|
$446K |
| 5 |
VanEck Gold Miners ETF
GDX
|
$313K |
Sector Composition
| 1 | Materials | 40.3% |
| 2 | Healthcare | 38.22% |
| 3 | Technology | 13.88% |
| 4 | Financials | 3.76% |
| 5 | Communication Services | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
1
New Gold Inc
NGD
$4.67B
| $16.1M | 36.69% |
6,500,000
+1,412,003
| +28% | +$3.5M |
|
|
2
StoneCo
STNE
$4.41B
| $6.1M | 13.87% |
764,797
-319,561
| -29% | -$2.55M |
|
3
Eli Lilly
LLY
$657B
| $1.84M | 4.19% |
2,387
-2
| -0.1% | -$1.54K |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.73M | 3.94% |
9,374
-1
| -0% | -$185 |
|
5
Incyte
INCY
$16.5B
| $1.7M | 3.87% |
24,633
| – | – |
|
6
Intuitive Surgical
ISRG
$170B
| $1.47M | 3.34% |
2,810
+878
| +45% | +$458K |
|
|
7
Telecom Argentina
TEO
$3.88B
| $853K | 1.94% |
+67,751
| New | +$853K |
|
|
8
Banco Macro
BMA
$3.7B
| $834K | 1.9% |
+8,617
| New | +$834K |
|
|
9
Galicia Financial Group
GGAL
$6.31B
| $820K | 1.87% |
+13,150
| New | +$820K |
|
|
10
YPF
YPF
$12B
| $817K | 1.86% |
+19,210
| New | +$817K |
|
|
LOMA
11
Loma Negra
LOMA
$1.09B
| $785K | 1.79% |
+65,786
| New | +$785K |
|
12
Thermo Fisher Scientific
TMO
$186B
| $740K | 1.68% |
1,422
-1
| -0.1% | -$520 |
|
|
13
UnitedHealth
UNH
$281B
| $698K | 1.59% |
1,380
-882
| -39% | -$446K |
|
14
Stryker
SYK
$150B
| $670K | 1.53% |
1,862
-2
| -0.1% | -$720 |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $635K | 1.45% |
34,620
| – | – |
|
16
argenx
ARGX
$43.6B
| $616K | 1.4% |
1,002
-1
| -0.1% | -$615 |
|
17
Madrigal Pharmaceuticals
MDGL
$9.76B
| $615K | 1.4% |
1,993
| – | – |
|
18
Danaher
DHR
$147B
| $567K | 1.29% |
2,472
-2
| -0.1% | -$459 |
|
19
Merck
MRK
$210B
| $567K | 1.29% |
5,695
-5
| -0.1% | -$497 |
|
20
Agnico Eagle Mines
AEM
$72.4B
| $508K | 1.16% |
6,497
| – | – |
|
21
Elevance Health
ELV
$71.8B
| $452K | 1.03% |
1,226
-1
| -0.1% | -$369 |
|
22
Insmed
INSM
$28.8B
| $423K | 0.96% |
6,120
-3
| -0% | -$207 |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $390K | 0.89% |
968
-1
| -0.1% | -$403 |
|
24
Regeneron Pharmaceuticals
REGN
$61.5B
| $383K | 0.87% |
538
-1
| -0.2% | -$712 |
|
25
AstraZeneca
AZN
$248B
| $378K | 0.86% |
5,762
-6
| -0.1% | -$393 |
|